Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ataraxis Real-World Clinical Outcomes: A Prospective, Multi-Site, Observational Registry Linking AI-Based Pathology Scores With Short- and Long-Term Outcomes

NCT07706842 is registered in ClinicalTrials.gov with Ataraxis AI, Inc. as lead sponsor.

NCT NCT07706842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07706842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ataraxis Real-World Clinical Outcomes: A Prospective, Multi-Site, Observational Registry Linking AI-Based Pathology Scores With Short- and Long-Term Outcomes
Lead sponsor
Ataraxis AI, Inc.
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
December 31, 2038
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, solid tumor malignancy